Patent Assignment
Reel/Frame 059046/0858
Merger and Change of Name
Recorded: 2022-02-18
Pages: 6
Assignors
DIMENSION THERAPEUTICS, INC.
Executed: 2019-03-08
ULTRAGENYX PHARMACEUTICAL INC.
Executed: 2019-03-08
Assignee
ULTRAGENYX PHARMACEUTICAL INC.
60 LEVERONI COURT, NOVATO, CALIFORNIA, 94949
Covered Properties
(4)
Methods of Heat Inactivation of Adenovirus
Methods for Enhancing Yield of Recombinant Adeno-Associated Virus
Application:
16/495,974 →
Publication:
US 2020/0048641
Cell Culture Methods Involving Hdac Inhibitors or Rep Proteins
Scalable Method for Producing Transfection Reagents
Application:
16/612,002 →
Publication:
US 2020/0124505
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 18, 2022
From: JING, YING; PANTELI, JAN; CLARK, KELLY R.
To: DIMENSION THERAPEUTICS, INC.
Reel/Frame 059046/0615 →
Assignment of Assignor's Interest
Feb 18, 2022
From: TIERNAN, AUBREY; TIPPER, CHRISTOPHER
To: DIMENSION THERAPEUTICS, INC.
Reel/Frame 059046/0626 →
Assignment of Assignor's Interest
Feb 18, 2022
From: PANTELI, JAN; JING, YING
To: DIMENSION THERAPEUTICS, INC.
Reel/Frame 059046/0833 →
Assignment of Assignor's Interest
Feb 18, 2022
From: MORRISON, CHRISTOPHER J.; MARATT, JAMES D.
To: DIMENSION THERAPEUTICS, INC.
Reel/Frame 059046/0432 →